Membership supports GRP Japan’s expanding capabilities in radiopharmaceuticals and nuclear medicine
| TOKYO, JAPAN October 2026 | MEMBERSHIP Japan Radiopharmaceuticals Association | BUSINESS EXPANSION Radiopharmaceuticals |
Link to Document HERE
Tokyo, Japan — October 2026 — Global Regulatory Partners Japan (GRP Japan) is pleased to announce that it has joined the Japan Radiopharmaceuticals Association, effective October 2026.
The membership marks an important step in GRP Japan’s continued expansion into the radiopharmaceutical and nuclear medicine sector, complementing the company’s established capabilities in pharmaceuticals, biologics, medical devices, and diagnostics.
As a Marketing Authorization Holder (MAH) and local regulatory partner for international healthcare companies entering Japan, GRP Japan is expanding its capabilities to support the specialized regulatory, quality, importation, supply-chain, and lifecycle requirements associated with radiopharmaceutical products. Through its membership, GRP Japan looks forward to industry collaboration and to contributing its regulatory and market-access experience to the continued development of the sector in Japan.
| “ Radiopharmaceuticals represent an important and growing area of healthcare innovation, where successful market access requires close coordination across regulatory, quality, supply-chain, and healthcare stakeholders. Joining the Japan Radiopharmaceuticals Association is an important step in the continued development of GRP Japan’s capabilities. We look forward to collaborating with industry members and contributing our experience in supporting global healthcare companies in Japan.” — Suzan Davis, President & CEO, Global Regulatory Partners |
ORGANIZATION PROFILES
| ABOUT THE ASSOCIATION The Japan Radiopharmaceuticals Association promotes the healthy development of the radiopharmaceutical industry. Its activities include collaboration among member companies, initiatives supporting the stable manufacture and supply of radiopharmaceuticals with assured quality, efficacy, and safety, addressing issues affecting radiopharmaceutical use, developing voluntary standards, and promoting stakeholder understanding of nuclear medicine and radiopharmaceuticals. | ABOUT GRP JAPAN Established in Tokyo in 2016, Global Regulatory Partners Japan supports pharmaceutical, biotechnology, medical device, diagnostic, and other healthcare companies entering and operating in Japan. GRP Japan provides regulatory, MAH, quality, safety, medical information, importation, supply-chain, and lifecycle support as part of the Global Regulatory Partners Group, with expanding capabilities for radiopharmaceutical products. |
| 2026 MARKS GRP JAPAN’S 10TH ANNIVERSARY • A DECADE OF PARTNERSHIP. A HEALTHIER TOMORROW. |
MEDIA & COMPANY INFORMATION
Global Regulatory Partners Japan | globalregulatorypartners.com | globalregulatorypartners.co.jp
